Tech News
← Home  ·  All topics

Immunology

2 GoKawiil briefs on this topic

Study finds dural cancer metastases hijack bone cells to damage brain lymphatic vessels

Researchers led by Zeng et al., publishing in Nature, report that tumours spreading to the dura—the brain's outer membrane—recruit bone-degrading osteoclast cells. These osteoclasts damage nearby meningeal lymphatic vessels, which normally drain fluid from around the brain, and weaken local immune defences against the tumour.

Eli Lilly to Acquire Merida Biosciences for Up to $2.875 Billion

Eli Lilly has struck a cash deal worth as much as $2.875 billion to acquire Merida Biosciences, a biotechnology company. The acquisition is aimed at strengthening Lilly's immunology drug pipeline.